Diagnamed Holdings Corp. (DMED.CN)

0.0400 -0.0050 (-11.11%) At close: 11:16AM EDT

Diagnamed Holdings Corp.

82 Richmond Street East
Toronto, ON M5C 1P1
Canada
416-800-2684
https://www.diagnamed.com

Sector(s): Healthcare
Industry: Health Information Services
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Fabio Chianelli	Chairman, President & CEO	180k	N/A	1978
Mr. Jing Peng C.A., CPA, CA, CPA, MMPA	Chief Financial Officer	64.93k	N/A	1977
Mr. Andrew Newbury CPA	Corporate Secretary	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Diagnamed Holdings Corp., a digital health artificial intelligence company, engages in the development and commercialization of digital therapeutics for people suffering from mental health and neurological disorders. It focuses on CERVAI, a brain health AI platform; and Health GenAI, a suite of generative AI solutions for the healthcare market that includes OpenAI's ChatGPT. The company also develops Dr. GENAI, a personal AI medical chatbot designed to give people to obtain fast and personalized medical information based on a person's unique medical condition. In addition, it is developing Brain Age, an electroencephalogram-based (EEG) machine-learning solution to detect an individual's brain age for use in clinic and at-home. The company is headquartered in Toronto, Canada.

Corporate Governance

Diagnamed Holdings Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.